Bioorthogonal transition metal catalysts (TMCs) transform therapeutically inactive molecules
(pro-drugs) into active drug compounds. Inorganic nanoscaffolds protect and solubilize …

Bioorthogonal chemistry is a promising toolbox for dissecting biological processes in the
native environment. Recently, bioorthogonal reactions have attracted considerable attention …

As one of the most typical bioorthogonal reactions, the Cu (I)-catalyzed azide–alkyne 1, 3-
cycloaddition (CuAAC) reaction has received worldwide attention in intracellular …

Nanomaterials that can mimic the activity of various enzymes have been studied extensively
in the biomedical field in recent years. Nanozymes offer better stability and economic value …

Antimicrobial resistance, caused by persistent adaptation and growing resistance of
pathogenic bacteria to overprescribed antibiotics, poses one of the most serious and urgent …

Bioorthogonal catalysis via transition metal catalysts (TMCs) enables the generation of
therapeutics locally through chemical reactions not accessible by biological systems. This …

Misguided attack of immune systems on self-tissue or multifactorial uncontrolled
inflammation is capable of causing inflammatory diseases. Neutrophils play a critical role in …

Clinical treatment of multidrug resistant (MDR) pathogens‐induced infection is emerging as
a growing challenge in global public health due to the limited selection of clinically available …

In the past five decades, red blood cells (RBCs) have been extensively explored as drug
delivery systems due to their distinguishing potential in modulating the pharmacokinetic …

Red blood cells (RBCs) are the most abundant cells in the body, possessing unique
biological and physical properties. RBCs have demonstrated outstanding potential as …